0001821806false--09-28Q30001821806us-gaap:RevolvingCreditFacilityMember2023-09-300001821806us-gaap:AdditionalPaidInCapitalMember2024-03-3100018218062024-04-012024-06-290001821806lesl:ABRMemberlesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMemberlesl:TermLoanMemberlesl:ApplicableRateMember2023-06-012023-06-3000018218062023-04-010001821806us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-290001821806us-gaap:BaseRateMemberlesl:ABLCreditFacilityMembersrt:MaximumMember2023-10-012024-06-290001821806us-gaap:RetainedEarningsMember2023-10-012024-06-290001821806lesl:TermLoanMember2023-06-012023-06-300001821806us-gaap:BaseRateMemberlesl:ABLCreditFacilityMembersrt:MinimumMember2023-10-012024-06-290001821806us-gaap:PerformanceSharesMembersrt:MaximumMember2023-10-012024-06-290001821806us-gaap:EmployeeStockOptionMember2023-04-022023-07-010001821806us-gaap:OtherIntangibleAssetsMember2023-07-010001821806lesl:TrademarksAndTradeNameMember2023-07-010001821806us-gaap:RestrictedStockUnitsRSUMember2023-04-022023-07-010001821806us-gaap:PerformanceSharesMembersrt:MinimumMember2023-10-012024-06-290001821806us-gaap:AdditionalPaidInCapitalMember2023-04-022023-07-0100018218062022-10-0100018218062023-04-022023-07-010001821806us-gaap:WorkersCompensationInsuranceMember2024-06-2900018218062022-10-022023-07-010001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberlesl:ABLCreditFacilityMembersrt:MaximumMember2023-10-012024-06-290001821806us-gaap:PerformanceSharesMember2023-10-012024-06-290001821806us-gaap:CommonStockMemberlesl:BubblesInvestorAggregatorLPAndExplorerInvestmentPteLtdMember2021-12-142021-12-140001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-022023-07-010001821806lesl:TermLoanMembersrt:MinimumMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMember2023-06-012023-06-300001821806lesl:GeneralLiabilityInsuranceProgramMembersrt:MaximumMember2024-06-290001821806us-gaap:DebtInstrumentRedemptionPeriodThreeMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-06-012023-06-300001821806us-gaap:AdditionalPaidInCapitalMember2023-10-012024-06-290001821806us-gaap:RetainedEarningsMember2024-04-012024-06-290001821806us-gaap:CommonStockMember2022-10-010001821806us-gaap:PerformanceSharesMembersrt:MinimumMember2022-12-012022-12-310001821806us-gaap:RetainedEarningsMember2022-10-010001821806lesl:TermLoanMember2023-06-300001821806us-gaap:OtherIntangibleAssetsMember2024-06-290001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2023-06-012023-06-300001821806us-gaap:AdditionalPaidInCapitalMember2022-10-010001821806us-gaap:CommonStockMember2024-06-290001821806us-gaap:CustomerRelationshipsMember2023-09-300001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2023-03-012023-03-310001821806us-gaap:CommonStockMember2021-12-032021-12-030001821806lesl:ABRMemberlesl:TermLoanMemberlesl:ApplicableRateMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMember2023-06-012023-06-300001821806lesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMemberlesl:TermLoanMembersrt:MaximumMember2023-06-012023-06-300001821806us-gaap:AdditionalPaidInCapitalMember2023-04-010001821806us-gaap:RevolvingCreditFacilityMember2023-03-012023-03-310001821806lesl:TermLoanMember2023-09-300001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberlesl:TermLoanMembersrt:MaximumMember2024-06-290001821806us-gaap:CommonStockMember2023-09-300001821806us-gaap:NoncompeteAgreementsMember2023-09-3000018218062024-08-0200018218062022-10-022023-09-300001821806us-gaap:RetainedEarningsMember2022-10-022023-07-0100018218062024-03-310001821806lesl:RestrictedStockUnitsAndPerformanceUnitsMember2023-10-012024-06-290001821806us-gaap:NoncompeteAgreementsMember2024-06-290001821806us-gaap:EmployeeStockOptionMember2024-03-312024-06-290001821806us-gaap:OtherIntangibleAssetsMember2023-09-300001821806us-gaap:RetainedEarningsMember2024-06-290001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-10-012024-06-290001821806us-gaap:CommonStockMember2023-04-022023-07-010001821806us-gaap:PerformanceSharesMembersrt:MaximumMember2022-12-012022-12-310001821806lesl:RestrictedStockUnitsAndPerformanceUnitsMember2023-09-300001821806us-gaap:RevolvingCreditFacilityMember2023-07-010001821806us-gaap:AdditionalPaidInCapitalMember2023-09-300001821806us-gaap:EmployeeStockOptionMember2023-10-012024-06-290001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberlesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMemberlesl:TermLoanMemberlesl:ApplicableRateMember2023-06-012023-06-300001821806us-gaap:TrademarksAndTradeNamesMember2023-09-300001821806us-gaap:RetainedEarningsMember2023-04-022023-07-010001821806lesl:ABRMemberlesl:TermLoanMemberlesl:ApplicableRateMember2023-06-012023-06-300001821806lesl:TrademarksAndTradeNameMember2022-10-022023-07-010001821806lesl:TermLoanMember2024-06-290001821806lesl:GeneralLiabilityInsuranceProgramMembersrt:MaximumMember2023-07-010001821806us-gaap:BaseRateMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMember2023-03-012023-03-310001821806lesl:GeneralLiabilityInsuranceProgramMembersrt:MaximumMember2023-09-300001821806lesl:RestrictedStockUnitsAndPerformanceUnitsMember2024-06-2900018218062024-06-290001821806us-gaap:CommonStockMember2024-03-152024-03-150001821806us-gaap:CommonStockMember2024-03-312024-06-290001821806us-gaap:CommonStockMember2021-12-160001821806us-gaap:TrademarksAndTradeNamesMember2024-06-290001821806us-gaap:CommonStockMember2022-10-022023-07-010001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MinimumMemberlesl:TermLoanMember2023-10-012024-06-290001821806us-gaap:CommonStockMember2023-04-010001821806srt:MinimumMemberlesl:BubblesInvestorAggregatorLPMember2021-12-1400018218062023-07-010001821806us-gaap:RetainedEarningsMember2024-03-310001821806lesl:TrademarksAndTradeNameMember2023-10-012024-06-2900018218062024-03-312024-06-290001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMember2023-03-012023-03-310001821806us-gaap:RetainedEarningsMember2023-07-010001821806us-gaap:AdditionalPaidInCapitalMember2022-10-022023-07-010001821806us-gaap:AdditionalPaidInCapitalMember2024-06-290001821806us-gaap:EmployeeStockOptionMember2023-09-300001821806lesl:TrademarksAndTradeNameMember2022-10-022023-09-300001821806us-gaap:RestrictedStockUnitsRSUMember2022-10-022023-07-010001821806us-gaap:EmployeeStockOptionMember2022-10-022023-07-010001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberlesl:ABLCreditFacilityMembersrt:MinimumMember2023-10-012024-06-290001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberlesl:TermLoanMembersrt:MinimumMember2024-06-290001821806us-gaap:CustomerRelationshipsMember2023-07-010001821806lesl:TrademarksAndTradeNameMember2023-09-300001821806us-gaap:NoncompeteAgreementsMember2023-07-010001821806us-gaap:RestrictedStockUnitsRSUMember2023-10-012024-06-290001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberlesl:TermLoanMemberlesl:ApplicableRateMember2023-06-012023-06-300001821806us-gaap:CommonStockMember2024-03-310001821806us-gaap:RevolvingCreditFacilityMember2024-04-032024-04-030001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-03-012023-03-310001821806lesl:ExplorerInvestmentPteLtdMembersrt:MinimumMember2021-12-140001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-03-312024-06-290001821806lesl:TermLoanMember2023-07-010001821806us-gaap:RevolvingCreditFacilityMemberus-gaap:InterestRateFloorMember2023-03-012023-03-310001821806us-gaap:CommonStockMember2021-12-012021-12-160001821806us-gaap:BaseRateMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-03-012023-03-310001821806us-gaap:DebtInstrumentRedemptionPeriodTwoMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-06-012023-06-300001821806us-gaap:CommonStockMember2023-07-010001821806lesl:TermLoanMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMembersrt:MaximumMember2023-06-012023-06-300001821806us-gaap:EmployeeStockOptionMember2023-10-012024-06-290001821806us-gaap:CommonStockMember2021-12-0300018218062023-10-012024-06-290001821806us-gaap:CustomerRelationshipsMember2024-06-290001821806lesl:TrademarksAndTradeNameMember2024-06-290001821806us-gaap:RestrictedStockUnitsRSUMember2024-03-312024-06-290001821806us-gaap:PerformanceSharesMember2022-12-012022-12-310001821806us-gaap:CommonStockMember2024-04-012024-06-290001821806lesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMemberlesl:TermLoanMembersrt:MinimumMember2023-06-012023-06-300001821806us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberlesl:TermLoanMemberlesl:ApplicableRateMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMember2023-06-012023-06-300001821806us-gaap:RetainedEarningsMember2023-09-300001821806us-gaap:EmployeeStockOptionMember2024-06-290001821806us-gaap:AdditionalPaidInCapitalMember2023-07-010001821806us-gaap:TrademarksAndTradeNamesMember2023-07-010001821806us-gaap:CommonStockMember2023-10-012024-06-290001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-10-022023-07-010001821806us-gaap:RetainedEarningsMember2023-04-010001821806us-gaap:RevolvingCreditFacilityMember2024-06-2900018218062023-09-300001821806us-gaap:RevolvingCreditFacilityMember2023-03-31iso4217:USDxbrli:sharesxbrli:purelesl:Statelesl:Locationxbrli:sharesiso4217:USD

 

9184

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 29, 2024

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO

Commission File Number: 001-39667

 

LESLIE’S, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

20-8397425

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2005 East Indian School Road

Phoenix, AZ

85016

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (602) 366-3999

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

LESL

 

The Nasdaq Global Select Market

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YesNo

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). YesNo

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YesNo

As of August 2, 2024, the Registrant had 184,912,804, shares of common stock, $0.001 par value per share, outstanding.

 

 

 


Table of Contents

Table of Contents

 

Page

PART I

FINANCIAL INFORMATION

Item 1.

Financial Statements

2

 

Condensed Consolidated Balance Sheets

2

 

Condensed Consolidated Statements of Operations

3

 

Condensed Consolidated Statements of Stockholders’ Deficit

4

 

Condensed Consolidated Statements of Cash Flows

5

 

Notes to the Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

24

Item 4.

Controls and Procedures

24

 

PART II

OTHER INFORMATION

 

Item 1.

Legal Proceedings

26

Item 1A.

Risk Factors

26

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

26

Item 3.

Defaults Upon Senior Securities

26

Item 4.

Mine Safety Disclosures

26

Item 5.

Other Information

26

Item 6.

Exhibits

27

 

 

 

Signatures

 

28

 

i


Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations or financial condition, business strategy, legal proceedings, competitive advantages, market size, growth opportunities, industry expectations, and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these words or other similar terms or expressions. Our actual results or outcomes could differ materially from those indicated in these forward-looking statements for a variety of reasons, including, among others:

our ability to execute on our growth strategies;
supply disruptions;
our ability to maintain favorable relationships with suppliers and manufacturers;
competition from mass merchants and specialty retailers;
impacts on our business from the sensitivity of our business to weather conditions, changes in the economy (including rising interest rates, recession fears, and inflationary pressures), geopolitical events or conflicts, and the housing market;
disruptions in the operations of our distribution centers;
our ability to implement technology initiatives that deliver the anticipated benefits, without disrupting our operations;
our ability to attract and retain senior management and other qualified personnel;
regulatory changes and development affecting our current and future products including evolving legal standards and regulations concerning environmental, social and governance (“ESG”) matters;
our ability to obtain additional capital to finance operations;
commodity price inflation and deflation;
impacts on our business from epidemics, pandemics, or natural disasters;
impacts on our business from cyber incidents and other security threats or disruptions;
our ability to remediate material weaknesses or other deficiencies in our internal control over financial reporting or to maintain effective disclosure controls and procedures and internal control over financial reporting; and
other risks and uncertainties, including those listed in the section titled “Risk Factors” in our filings with the United States Securities and Exchange Commission (“SEC”).

You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended September 30, 2023 and in our other filings with the SEC. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results or outcomes could differ materially from those described in the forward-looking statements.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q, and, while we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q are based on events or circumstances as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information, changed expectations, the occurrence of unanticipated events or otherwise, except as required by law. We may not actually achieve the plans, intentions, outcomes, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.

1


Table of Contents

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

LESLIE’S, INC.

CONDENSED Consolidated Balance Sheets

(Amounts in Thousands, Except Share and Per Share Amounts)

 

 

 

June 29, 2024

 

 

September 30, 2023

 

 

July 1, 2023

 

 

 

(Unaudited)

 

 

(Audited)

 

 

(Unaudited)

 

Assets

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

74,438

 

 

$

55,420

 

 

$

19,430

 

Accounts and other receivables, net

 

 

45,817

 

 

 

29,396

 

 

 

49,263

 

Inventories

 

 

302,209

 

 

 

311,837

 

 

 

436,557

 

Prepaid expenses and other current assets

 

 

34,545

 

 

 

23,633

 

 

 

31,454

 

Total current assets

 

 

457,009

 

 

 

420,286

 

 

 

536,704

 

Property and equipment, net

 

 

94,135

 

 

 

90,285

 

 

 

85,396

 

Operating lease right-of-use assets

 

 

282,556

 

 

 

251,460

 

 

 

250,378

 

Goodwill and other intangibles, net

 

 

216,041

 

 

 

218,855

 

 

 

219,835

 

Deferred tax assets

 

 

15,409

 

 

 

7,598

 

 

 

194

 

Other assets

 

 

40,038

 

 

 

45,951

 

 

 

44,918

 

Total assets

 

$

1,105,188

 

 

$

1,034,435

 

 

$

1,137,425

 

Liabilities and stockholders’ deficit

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accounts payable

 

$

108,935

 

 

$

58,556

 

 

$

147,436

 

Accrued expenses and other current liabilities

 

 

107,208

 

 

 

90,598

 

 

 

95,074

 

Operating lease liabilities

 

 

61,638

 

 

 

62,794

 

 

 

61,342

 

Income taxes payable

 

 

 

 

 

5,782

 

 

 

3,345

 

Current portion of long-term debt

 

 

8,100

 

 

 

8,100

 

 

 

8,100

 

Total current liabilities

 

 

285,881

 

 

 

225,830

 

 

 

315,297

 

Operating lease liabilities, noncurrent

 

 

216,756

 

 

 

193,222

 

 

 

193,004

 

Revolving Credit Facility

 

 

 

 

 

 

 

 

31,000

 

Long-term debt, net

 

 

768,598

 

 

 

773,276

 

 

 

774,884

 

Other long-term liabilities

 

 

2,110

 

 

 

3,469

 

 

 

3,050

 

Total liabilities

 

 

1,273,345

 

 

 

1,195,797

 

 

 

1,317,235

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Stockholders’ deficit

 

 

 

 

 

 

 

 

 

Common stock, $0.001 par value, 1,000,000,000 shares authorized and 184,912,804, 184,333,670, and 184,004,936 issued and outstanding as of June 29, 2024, September 30, 2023, and July 1, 2023, respectively.

 

 

185

 

 

 

184

 

 

 

184

 

Additional paid in capital

 

 

105,940

 

 

 

99,280

 

 

 

97,313

 

Retained deficit

 

 

(274,282

)

 

 

(260,826

)

 

 

(277,307

)

Total stockholders’ deficit

 

 

(168,157

)

 

 

(161,362

)

 

 

(179,810

)

Total liabilities and stockholders’ deficit

 

$

1,105,188

 

 

$

1,034,435

 

 

$

1,137,425

 

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

2


Table of Contents

LESLIE’S, INC.

CONDENSED Consolidated Statements of Operations

(Amounts in Thousands, Except Per Share Amounts)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

June 29, 2024

 

 

July 1, 2023

 

 

June 29, 2024

 

 

July 1, 2023

 

Sales

 

$

569,638

 

 

$

610,891

 

 

$

932,262

 

 

$

1,018,839

 

Cost of merchandise and services sold

 

 

340,798

 

 

 

359,295

 

 

 

598,686

 

 

 

630,777

 

Gross profit

 

 

228,840

 

 

 

251,596

 

 

 

333,576

 

 

 

388,062

 

Selling, general and administrative expenses

 

 

131,145

 

 

 

135,789

 

 

 

302,879

 

 

 

324,427

 

Operating income

 

 

97,695

 

 

 

115,807

 

 

 

30,697

 

 

 

63,635

 

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

18,156

 

 

 

17,675

 

 

 

53,380

 

 

 

48,282

 

Total other expense

 

 

18,156

 

 

 

17,675

 

 

 

53,380

 

 

 

48,282

 

Income (loss) before taxes

 

 

79,539

 

 

 

98,132

 

 

 

(22,683

)

 

 

15,353

 

Income tax expense (benefit)

 

 

18,889

 

 

 

25,585

 

 

 

(9,227

)

 

 

4,592

 

Net income (loss)

 

$

60,650

 

 

$

72,547

 

 

$

(13,456

)

 

$

10,761

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.33

 

 

$

0.39

 

 

$

(0.07

)

 

$

0.06

 

Diluted

 

$

0.33

 

 

$

0.39

 

 

$

(0.07

)

 

$

0.06

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

184,834

 

 

 

183,932

 

 

 

184,614

 

 

 

183,725

 

Diluted

 

 

184,861

 

 

 

184,760

 

 

 

184,614

 

 

 

184,752

 

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

3


Table of Contents

LESLIE’S, INC.

CONDENSED Consolidated Statements of Stockholders’ Deficit

(Amounts in Thousands)

(Unaudited)

 

 

 

Common Stock

 

 

Additional

 

 

 

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Paid in Capital

 

 

Retained Deficit

 

 

Stockholders’ Deficit

 

Balance, April 1, 2023

 

 

183,843

 

 

$

184

 

 

$

94,705

 

 

$

(349,854

)

 

$

(254,965

)

Issuance of common stock under the Plan

 

 

166

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity-based compensation

 

 

 

 

 

 

 

 

2,649

 

 

 

 

 

 

2,649

 

Restricted stock units surrendered in lieu of withholding taxes

 

 

(4

)

 

 

 

 

 

(41

)

 

 

 

 

 

(41

)

Net income

 

 

 

 

 

 

 

 

 

 

 

72,547

 

 

 

72,547

 

Balance, July 1, 2023

 

 

184,005

 

 

$

184

 

 

$

97,313

 

 

$

(277,307

)

 

$

(179,810

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2024

 

 

184,743

 

 

$

185

 

 

$

103,775

 

 

$

(334,932

)

 

$

(230,972

)

Issuance of common stock under the Plan

 

 

186

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity-based compensation

 

 

 

 

 

 

 

 

2,246

 

 

 

 

 

 

2,246

 

Restricted stock units surrendered in lieu of withholding taxes

 

 

(16

)

 

 

 

 

 

(81

)

 

 

 

 

 

(81

)

Net income

 

 

 

 

 

 

 

 

 

 

 

60,650

 

 

 

60,650

 

Balance, June 29, 2024

 

 

184,913

 

 

$

185

 

 

$

105,940

 

 

$

(274,282

)

 

$

(168,157

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Additional

 

 

 

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Paid in Capital

 

 

Retained Deficit

 

 

Stockholders’ Deficit

 

Balance, October 1, 2022

 

 

183,481

 

 

$

183

 

 

$

89,934

 

 

$

(288,068

)

 

$

(197,951

)

Issuance of common stock under the Plan

 

 

643

 

 

 

1

 

 

 

 

 

 

 

 

 

1

 

Equity-based compensation

 

 

 

 

 

 

 

 

9,159

 

 

 

 

 

 

9,159

 

Restricted stock units surrendered in lieu of withholding taxes

 

 

(119

)

 

 

 

 

 

(1,780

)

 

 

 

 

 

(1,780

)

Net income

 

 

 

 

 

 

 

 

 

 

 

10,761

 

 

 

10,761

 

Balance, July 1, 2023

 

 

184,005

 

 

$

184

 

 

$

97,313

 

 

$

(277,307

)

 

$

(179,810

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, September 30, 2023

 

 

184,334

 

 

$

184

 

 

$

99,280

 

 

$

(260,826

)

 

$

(161,362

)

Issuance of common stock under the Plan

 

 

727

 

 

 

1

 

 

 

 

 

 

 

 

 

1

 

Equity-based compensation

 

 

 

 

 

 

 

 

7,629

 

 

 

 

 

 

7,629

 

Restricted stock units surrendered in lieu of withholding taxes

 

 

(148

)

 

 

 

 

 

(969

)

 

 

 

 

 

(969

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

(13,456

)

 

 

(13,456

)

Balance, June 29, 2024

 

 

184,913

 

 

$

185

 

 

$

105,940

 

 

$

(274,282

)

 

$

(168,157

)

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

4


Table of Contents

LESLIE’S, INC.

CONDENSED Consolidated Statements of Cash Flows

(Amounts in Thousands)

(Unaudited)

 

 

Nine Months Ended

 

 

 

June 29, 2024

 

 

July 1, 2023

 

Operating Activities

 

 

 

 

 

 

Net income (loss)

 

$

(13,456

)

 

$

10,761

 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

24,420

 

 

 

25,569

 

Equity-based compensation

 

 

7,629

 

 

 

9,159

 

Amortization of deferred financing costs and debt discounts

 

 

1,647

 

 

 

1,541

 

Provision for doubtful accounts

 

 

1,007

 

 

 

25

 

Deferred income taxes

 

 

(7,811

)

 

 

1,074

 

Loss on asset dispositions

 

 

52

 

 

 

103

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts and other receivables

 

 

(17,428

)

 

 

(3,399

)

Inventories

 

 

9,628

 

 

 

(70,393

)

Prepaid expenses and other current assets

 

 

(10,912

)

 

 

(9,614

)

Other assets

 

 

6,561

 

 

 

(8,864

)

Accounts payable

 

 

50,379

 

 

 

(9,019

)

Accrued expenses and other current liabilities

 

 

14,428

 

 

 

(12,827

)

Income taxes payable

 

 

(5,782

)

 

 

(9,166

)

Operating lease assets and liabilities, net

 

 

48

 

 

 

237

 

Net cash provided by (used in) operating activities

 

 

60,410

 

 

 

(74,813

)

Investing Activities

 

 

 

 

 

 

Purchases of property and equipment

 

 

(34,324

)

 

 

(26,733

)

Business acquisitions, net of cash acquired

 

 

 

 

 

(15,549

)

Proceeds from asset dispositions

 

 

77

 

 

 

1,384

 

Net cash used in investing activities

 

 

(34,247

)

 

 

(40,898

)

Financing Activities

 

 

 

 

 

 

Borrowings on Revolving Credit Facility

 

 

140,500

 

 

 

264,000

 

Payments on Revolving Credit Facility

 

 

(140,500

)

 

 

(233,000

)

Repayment of long-term debt

 

 

(6,075

)

 

 

(6,075

)

Payment of deferred financing costs

 

 

(101

)

 

 

(297

)

Payments of employee tax withholdings related to restricted stock vesting

 

 

(969

)

 

 

(1,780

)

Net cash (used in) provided by financing activities

 

 

(7,145

)

 

 

22,848

 

Net increase (decrease) in cash and cash equivalents

 

 

19,018

 

 

 

(92,863

)

Cash and cash equivalents, beginning of period

 

 

55,420

 

 

 

112,293

 

Cash and cash equivalents, end of period

 

$

74,438

 

 

$

19,430

 

Supplemental Information:

 

 

 

 

 

 

Cash paid for interest

 

$

51,762

 

 

$

46,413

 

Cash paid for income taxes, net of refunds received

 

 

6,702

 

 

 

12,648

 

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

5


Table of Contents

LESLIE’S, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1—Business and Operations

Leslie’s, Inc. (“Leslie’s,” “we,” “our,” “us,” “its,” or the “Company”) is the leading direct-to-consumer pool and spa care brand. We market and sell pool and spa supplies and related products and services, which primarily consist of maintenance items such as chemicals, equipment and parts, and cleaning accessories, as well as safety, recreational, and fitness-related products. We currently market our products through over 1,000 company-operated locations in 39 states and e-commerce websites.

Note 2—Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

We prepared the accompanying interim condensed consolidated financial statements following United States generally accepted accounting principles (“GAAP”). The financial statements include all normal and recurring adjustments that are necessary for a fair presentation of our financial position and operating results. The interim condensed consolidated financial statements include the accounts of Leslie’s, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated. These interim condensed consolidated financial statements and the related notes should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended September 30, 2023.

Reclassification

Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on our results of operations.

Fiscal Periods

We operate on a fiscal calendar that results in a fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to September 30th. In a 52-week fiscal year, each quarter contains 13 weeks of operations; in a 53-week fiscal year, each of the first, second and third quarters includes 13 weeks of operations and the fourth quarter includes 14 weeks of operations. References to the three months ended June 29, 2024 and July 1, 2023 refer to the 13 weeks ended June 29, 2024 and July 1, 2023, respectively. References to the nine months ended June 29, 2024 and July 1, 2023 refer to the 26 weeks ended June 29, 2024 and July 1, 2023, respectively.

Use of Estimates

Management is required to make certain estimates and assumptions during the preparation of the condensed consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements. They also impact the reported amount of net income (loss) during any period. Actual results could differ from those estimates.

Significant estimates underlying the accompanying condensed consolidated financial statements include inventory reserves, lease assumptions, vendor rebate programs, our loyalty program, the determination of income taxes payable and deferred income taxes, sales returns reserve, self-insurance liabilities, the recoverability of intangible assets and goodwill, fair value of assets acquired in a business combination, and contingent consideration related to business combinations.

Seasonality

Our business is highly seasonal. Sales and earnings are highest during our third and fourth fiscal quarters, being April through September, which represent the peak months of swimming pool use. Sales are substantially lower during our first and second fiscal quarters.

Summary of Other Significant Accounting Policies

There have been no changes to our Significant Accounting Policies since our Annual Report on Form 10-K for the year ended September 30, 2023. For more information regarding our Significant Accounting Policies and Estimates, see Note 2—Summary of Significant Accounting Policies included in our Annual Report on Form 10-K for the year ended September 30, 2023.

6


Table of Contents

Recent Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This update is effective for annual periods beginning after December 15, 2024, though early adoption is permitted. We are currently evaluating the ASU to determine its impact on our disclosures; however, we do not expect there to be a material impact.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which require an entity to disclose the title and position of the Chief Operating Decision Maker (“CODM”) and the significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss. This update is effective for annual periods beginning after December 15, 2023 and interim disclosures beginning after December 15, 2024, though early adoption is permitted. This update is effective retrospectively upon adoption to all periods presented in the financial statements. We are currently evaluating the ASU to determine its impact on our disclosures; however, we do not expect there to be a material impact.

Note 3 —Goodwill and Other Intangibles, Net

Goodwill

The following table details the changes in goodwill (in thousands):

 

 

 

June 29, 2024

 

 

September 30, 2023

 

 

July 1, 2023

 

Balance at beginning of the period

 

$

180,698

 

 

$

173,513

 

 

$

173,513

 

Acquisitions, net of measurement period adjustments

 

 

 

 

 

7,185

 

 

 

7,185

 

Balance at the end of the period

 

$

180,698

 

 

$

180,698

 

 

$

180,698

 

Other Intangible Assets

Other intangible assets consisted of the following as of June 29, 2024 (in thousands, except weighted average remaining useful life):

 

 

Weighted
Average
Remaining
Useful Life
(in Years)

 

 

Gross
Carrying
Value

 

 

Accumulated
Amortization

 

 

Net
Carrying
Amount

 

Trade name and trademarks (finite life)

 

 

9.2

 

 

$

22,100

 

 

$

(4,861

)

 

$

17,239

 

Trade name and trademarks (indefinite life)

 

Indefinite

 

 

 

9,350

 

 

 

 

 

 

9,350

 

Non-compete agreements

 

 

4.6

 

 

 

2,260

 

 

 

(1,317

)

 

 

943

 

Consumer relationships

 

 

6.8

 

 

 

15,400

 

 

 

(7,685

)

 

 

7,715

 

Other intangibles

 

 

4.3

 

 

 

4,000

 

 

 

(3,904

)

 

 

96

 

Total

 

 

 

 

$

53,110

 

 

$

(17,767

)

 

$

35,343

 

 

Other intangible assets consisted of the following as of September 30, 2023 (in thousands, except weighted average remaining useful life):

 

 

Weighted
Average
Remaining
Useful Life
(in Years)

 

 

Gross
Carrying
Value

 

 

Accumulated
Amortization

 

 

Net
Carrying
Amount

 

Trade name and trademarks (finite life)

 

 

9.8

 

 

$

26,740

 

 

$

(7,958

)

 

$

18,782

 

Trade name and trademarks (indefinite life)

 

Indefinite

 

 

 

9,350

 

 

 

 

 

 

9,350

 

Non-compete agreements

 

 

5.4

 

 

 

8,683

 

 

 

(7,585

)

 

 

1,098

 

Consumer relationships

 

 

7.4

 

 

 

24,100

 

 

 

(15,317

)

 

 

8,783

 

Other intangibles

 

 

5.1

 

 

 

6,620

 

 

 

(6,476

)

 

 

144

 

Total

 

 

 

 

$

75,493

 

 

$

(37,336

)

 

$

38,157

 

 

7


Other intangible assets consisted of the following as of July 1, 2023 (in thousands, except weighted average remaining useful life):

 

 

Weighted
Average
Remaining
Useful Life
(in Years)

 

 

Gross
Carrying
Value

 

 

Accumulated
Amortization

 

 

Net
Carrying
Amount

 

Trade name and trademarks (finite life)

 

 

10.1

 

 

$

26,740

 

 

$

(7,436

)

 

$

19,304

 

Trade name and trademarks (indefinite life)

 

Indefinite

 

 

 

9,350

 

 

 

 

 

 

9,350

 

Non-compete agreements

 

 

5.6

 

 

 

8,683

 

 

 

(7,534

)

 

 

1,149

 

Consumer relationships

 

 

7.6

 

 

 

24,100

 

 

 

(14,935

)

 

 

9,165

 

Other intangibles

 

 

5.3

 

 

 

6,620

 

 

 

(6,451

)

 

 

169

 

Total

 

 

 

 

$

75,493

 

 

$

(36,356

)

 

$

39,137

 

 

Amortization expense was $0.9 million and $1.1 million for the three months ended June 29, 2024 and July 1, 2023, respectively. Amortization expense was $2.8 million and $3.4 million for the nine months ended June 29, 2024 and July 1, 2023, respectively. No impairment of goodwill or other intangible assets was recorded during the three and nine months ended June 29, 2024 and July 1, 2023.

The following table summarizes the estimated future amortization expense related to finite-lived intangible assets on our condensed consolidated balance sheet as of June 29, 2024 (in thousands):

 

 

Amount

 

Remainder of fiscal 2024

 

$

914

 

2025

 

 

3,632

 

2026

 

 

3,385

 

2027

 

 

3,262

 

2028

 

 

3,154

 

Thereafter

 

 

11,646

 

Total

 

$

25,993

 

 

Note 4—Accounts and Other Receivables, Net

Accounts and other receivables, net consisted of the following (in thousands):

 

 

 

June 29, 2024

 

 

September 30, 2023

 

 

July 1, 2023

 

Vendor and other rebates receivable

 

$

20,393

 

 

$

6,818

 

 

$

23,298

 

Customer receivables

 

 

21,592

 

 

 

18,334

 

 

 

21,175

 

Other receivables

 

 

6,031

 

 

 

5,900

 

 

 

6,436

 

Allowance for doubtful accounts

 

 

(2,199

)

 

 

(1,656

)

 

 

(1,646

)

Total

 

$

45,817

 

 

$

29,396

 

 

$

49,263

 

 

Note 5—Inventories

Inventories consisted of the following (in thousands):

 

 

 

June 29, 2024

 

 

September 30, 2023

 

 

July 1, 2023

 

Raw materials

 

$

4,787

 

 

$

3,076

 

 

$

8,342

 

Finished goods

 

 

297,422

 

 

 

308,761

 

 

 

428,215

 

Total

 

$

302,209

 

 

$

311,837

 

 

$

436,557

 

 

8


 

Note 6—Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

 

 

June 29, 2024

 

 

September 30, 2023

 

 

July 1, 2023

 

Prepaid insurance

 

$

3,449

 

 

$

1,236

 

 

$

3,629

 

Prepaid occupancy costs

 

 

2,173

 

 

 

1,967

 

 

 

1,955

 

Prepaid sales tax

 

 

6,788

 

 

 

4,060

 

 

 

7,679

 

Prepaid maintenance

 

 

5,038

 

 

 

4,426

 

 

 

2,492

 

Prepaid other

 

 

5,626

 

 

 

1,813

 

 

 

1,816

 

Income taxes receivable

 

 

2,337

 

 

 

 

 

 

 

Other current assets

 

 

9,134

 

 

 

10,131

 

 

 

13,883

 

Total

 

$

34,545

 

 

$

23,633

 

 

$

31,454

 

 

Note 7—Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

 

 

 

June 29, 2024

 

 

September 30, 2023

 

 

July 1, 2023

 

Accrued payroll and employee benefits

 

 

12,484

 

 

 

18,558

 

 

 

14,437

 

Customer deposits

 

 

5,428

 

 

 

7,356

 

 

 

7,477

 

Interest

 

 

555

 

 

 

581

 

 

 

630

 

Inventory related accruals

 

 

14,323

 

 

 

13,843

 

 

 

23,635

 

Loyalty and deferred revenue

 

 

6,685

 

 

 

6,785

 

 

 

5,932

 

Sales tax

 

 

15,442

 

 

 

9,146

 

 

 

15,729

 

Self-insurance reserves

 

 

11,228

 

 

 

9,138

 

 

 

9,517

 

Other accrued liabilities

 

 

41,063

 

 

 

25,191

 

 

 

17,717

 

Total

 

$

107,208

 

 

$

90,598

 

 

$

95,074

 

As of June 29, 2024, September 30, 2023, and July 1, 2023, capital expenditures included in other accrued liabilities were $2.0 million, $1.5 million, and $0.9 million, respectively.

Note 8—Long-Term Debt, Net

Our long-term debt, net consisted of the following (in thousands, except interest rates):

 

 

 

Effective
Interest Rate
(1)

 

 

June 29, 2024

 

 

September 30, 2023

 

 

July 1, 2023

 

Term Loan

 

 

8.19

%

(2)

$

783,675

 

 

$

789,750

 

 

$

791,775

 

Revolving Credit Facility

 

 

6.72

%

(3)

 

 

 

 

 

 

 

31,000

 

Total long-term debt

 

 

 

 

 

783,675

 

 

 

789,750

 

 

 

822,775

 

Less: current portion of long-term debt

 

 

 

 

 

(8,100

)

 

 

(8,100

)

 

 

(8,100

)

Less: noncurrent Revolving Credit Facility

 

 

 

 

 

 

 

 

 

 

 

(31,000

)

Less: unamortized discount

 

 

 

 

 

(1,944

)

 

 

(2,316

)

 

 

(2,439

)

Less: deferred financing charges

 

 

 

 

 

(5,033

)

 

 

(6,058

)

 

 

(6,352

)

Total long-term debt, net

 

 

 

 

$

768,598

 

 

$

773,276

 

 

$

774,884

 

 

(1)
Effective interest rates as of June 29, 2024.
(2)
Carries interest at a specified margin over the Term Secured Overnight Financing Rate (“SOFR”) between 2.50% and 2.75% with a minimum SOFR of 0.50% plus a SOFR adjustment.
(3)
Carries interest at a specific margin between 0.25% and 0.75% with respect to base rate loans and between 1.25% and 1.75% with respect to Term SOFR loans, with a SOFR adjustment.

 

9


Table of Contents

Term Loan

In June 2023, we entered into Amendment No. 1 (“Term Loan Amendment”) to our Amended and Restated Term Loan Credit Agreement (“Term Loan”). The Term Loan Amendment (i) replaced the existing LIBOR-based interest rate benchmark with a Term SOFR-based benchmark and (ii) amended certain other related terms and provisions, including the addition of a SOFR adjustment of (a) 0.11448% per annum for one-month, (b) 0.26161% per annum for three months, and (c) 0.42826% per annum for six months. The other material terms of the Term Loan remained substantially unchanged.

The Term Loan provides for an $810.0 million secured term loan facility with a maturity date of March 9, 2028. Borrowings under the Term Loan have an initial applicable rate, at our option, of (i) 2.75% for loans that are Term SOFR loans and (ii) 1.75% for loans that are ABR loans (the “Applicable Rate”). The Applicable Rate of the Term Loan is based on our first lien leverage ratio as follows: (a) if the first lien leverage ratio is greater than 2.75 to 1.00, the applicable rate will be 2.75% for Term SOFR loans and 1.75% for ABR loans and (b) if the first lien leverage ratio is less than or equal to 2.75 to 1.00, the applicable rate will be 2.50% for Term SOFR loans and 1.50% for ABR loans. For Term SOFR loans, the loans will bear interest at the Term SOFR-based benchmark rate plus the Applicable Rate and the SOFR adjustment, as defined above.

Revolving Credit Facility

In March 2023, we entered into Amendment No. 6 to our $200.0 million credit facility (“Revolving Credit Facility”) maturing on August 13, 2025 (the “Amendment”). The Amendment (i) increased the revolving credit commitments under the Revolving Credit Facility in the amount of $50.0 million, such that the aggregate commitments are $250.0 million and (ii) replaced the existing LIBOR-based rate with a Term SOFR-based rate, as an interest rate benchmark. The Revolving Credit Facility has (i) an applicable margin on base rate loans with a range of 0.25% to 0.75%, (ii) an applicable margin on Term SOFR loans with a range of 1.25% and 1.75%, (iii) a SOFR Adjustment of 0.10% for all borrowing periods, (iv) a floor of 0% per annum, and (v) a commitment fee rate of 0.25% per annum. The other material terms of the Revolving Credit Facility prior to the Amendment remained substantially unchanged.

On April 3, 2024, we entered into Amendment No. 7 to our Revolving Credit Facility (the “2024 Amendment”). The 2024 Amendment (i) extended the maturity date to April 3, 2029 and (ii) revised the applicable margin on Term SOFR and base rate loans. The other material terms of the Revolving Credit Facility prior to the 2024 Amendment remained substantially unchanged.

As of June 29, 2024 and September 30, 2023, no amounts were outstanding on the Revolving Credit Facility. The amount available under our Revolving Credit Facility was reduced by $10.9 million and $11.4 million of existing standby letters of credit as of June 29, 2024 and September 30, 2023, respectively.

Representations and Covenants

Substantially all of our assets are pledged as collateral to secure our indebtedness. The Term Loan does not require us to comply with any financial covenants. The Term Loan and the Revolving Credit Facility contain customary representations and warranties, covenants, and conditions to borrowing. No event of default occurred as of June 29, 2024, September 30, 2023, and July 1, 2023.

Future Debt Maturities

The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of June 29, 2024 (in thousands):

 

 

Amount

 

Remainder of fiscal 2024

 

$

2,025

 

2025

 

 

10,125

 

2026

 

 

8,100

 

2027

 

 

8,100

 

2028

 

 

755,325

 

Thereafter

 

 

 

Total

 

$

783,675

 

 

 

10


Table of Contents

 

Note 9—Income Taxes

Our effective income tax rate was a benefit of 40.7% for the nine months ended June 29, 2024, compared to 29.9% for the nine months ended July 1, 2023. The difference between the statutory rate and our effective rate for the nine months ended June 29, 2024 and July 1, 2023 was primarily attributable to state taxes and net income tax expenses due to equity-based compensation awards. Our effective income tax rate can fluctuate due to factors including valuation allowances, changes in tax laws, federal and state audits, and the impact of other discrete items.

Note 10—Commitments & Contingencies

Contingencies

On September 8, 2023, a class action complaint for violation of federal securities laws was filed by West Palm Beach Police Pension Fund in the U.S. District Court for the District of Arizona against us, our Chief Executive Officer and our former Chief Financial Officer. On December 1, the court appointed lead plaintiff, and on February 20, 2024, the lead plaintiff filed an amended and consolidated complaint. The amended and consolidated complaint alleges that we violated federal securities laws by issuing materially false and misleading statements that failed to disclose adverse facts about our financial guidance, business operations and prospects, and seeks class certification, damages, interest, attorneys’ fees, and other relief. Due to the early stage of this proceeding, we cannot reasonably estimate the potential range of loss, if any. We dispute the allegations of wrongdoing and intend to defend ourselves vigorously in this matter.

On March 13, 2024 and March 14, 2024, derivative actions were separately filed in the U.S. District Court for the District of Arizona and Delaware by John Clemens and Sally Flynn, on behalf of the Company, against our officers and directors. Both complaints include substantially the same allegations as those in the securities class action, and allege that the defendant directors and officers harmed the Company by either making false or misleading statements, or allowing false or misleading statements to be made. The complaints seek the award of damages, costs and attorneys’ fees, and other declaratory relief. The parties in both the Arizona and Delaware derivative actions have filed stipulations to stay the actions pending resolution of the securities class action. Due to the early stage of these proceedings, we cannot reasonably estimate the potential range of loss, if any. We dispute the allegations of wrongdoing and intend to defend ourselves vigorously in these matters.

We are defendants in lawsuits or potential claims encountered in the normal course of business. When the potential liability from a matter can be estimated and the loss is considered probable, we record the estimated loss. Due to uncertainties related to the resolution of lawsuits, investigations and claims, the ultimate outcome may differ from the estimates. We do not expect that the resolutions of any of these matters will have a material effect on our condensed consolidated financial position or results of operations. We did not record any material loss contingencies as of June 29, 2024, September 30, 2023, and July 1, 2023.

Our workers’ compensation insurance program, general liability insurance program, and employee group medical plan have self-insurance retention features of up to $0.4 million per event as of June 29, 2024, September 30, 2023, and July 1, 2023. We had standby letters of credit outstanding in the amount of $10.9 million as of June 29, 2024 for the purpose of securing such obligations under our workers’ compensation self-insurance programs.

Note 11—Related Party Transactions

On December 14, 2021, the Company entered into a share repurchase agreement with Bubbles Investor Aggregator, L.P. and Explorer Investment Pte. Ltd. (together, the “Selling Stockholders”), each a greater than 5% beneficial owner of the Company’s common stock at the time of the transaction, providing for the repurchase by the Company from the Selling Stockholders of an aggregate of 7.5 million shares of common stock, conditioned on the closing of a contemporaneous secondary public offering (the “Offering”). The price per share of repurchased common stock paid by the Company was $20.25, which represents the per share price at which shares of common stock were sold to the public in the Offering less the underwriting discount. The repurchase transaction closed on December 16, 2021. See Note 12—Share Repurchase Program for detailed information regarding our share repurchase program.

11


Table of Contents

Note 12—Share Repurchase Program

On December 3, 2021, the board of directors authorized a share repurchase program for up to an aggregate of $300 million of the Company’s outstanding shares of common stock over a period of three years, expiring December 31, 2024. The amount, price, manner, and timing of repurchases are determined by the Company in its discretion and depends on a number of factors, including legal requirements, price, economic and market conditions, the Company’s financial condition, capital requirements, cash flows, results of operations, future business prospects, and other factors our management may deem relevant. The share repurchase program may be amended, suspended, or discontinued at any time. Shares may be repurchased from time-to-time using a variety of methods, including on the open market and/or in privately negotiated transactions, including under plans complying with Rule 10b5-1 under the Exchange Act, as part of accelerated share repurchases, and other methods.

On December 16, 2021, the Company repurchased and retired 7.5 million shares of common stock at a price per share of $20.25 under the program. The Company paid $151.9 million ($152.1 million including offering costs) to fund the share repurchase using existing cash on hand. The Company accounted for the share repurchase and retirement of shares under the cost method by deducting its par value from common stock, reducing additional paid-in-capital by $127.5 million (using the share price when the shares were originally issued), and increasing retained deficit by the remaining excess cost of $24.4 million.

As of June 29, 2024, approximately $147.7 million remained available for future purchases under our share repurchase program.

The following table presents information about our repurchases of common stock under our share repurchase program (in thousands):

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

June 29, 2024

 

 

July 1, 2023

 

 

June 29, 2024

 

 

July 1, 2023

 

Total number of shares repurchased

 

 

 

 

 

 

 

 

 

 

 

27

 

Total amount paid for shares repurchased

 

$

 

 

$

 

 

$

 

 

$

419

 

 

Note 13—Equity-Based Compensation

Equity-Based Compensation

2020 Omnibus Incentive Plan

In October 2020, we adopted the Leslie’s, Inc. 2020 Omnibus Incentive Plan (the “Plan”). The Plan was most recently amended and restated in March 2024. The Plan provides for the grant of awards such as non-qualified stock options to purchase Leslie’s common stock (each, a “Stock Option”), restricted stock units (“RSUs”) and performance stock units (“PSUs”) which may settle in Leslie’s, Inc. common stock to our directors, executives, and eligible employees of the Company. The vesting of the Company’s outstanding and unvested Stock Options, RSUs, and PSUs is contingent upon each holder’s continued service through the date of each applicable vesting event. On March 15, 2024 the Company’s shareholders approved an amendment to the Plan increasing the shares of common stock available for future grants by 7.2 million shares. As of June 29, 2024, we had approximately 14.4 million shares of common stock available for future grants under the Plan.

As of June 29, 2024, the aggregate unamortized value of all outstanding equity-based compensation awards was approximately $18.6 million, which is expected to be recognized over a weighted average period of approximately 2.5 years.

Stock Options

Stock Options granted under the Plan generally expire ten years from the date of grant and consist of Stock Options that vest upon the satisfaction of time-based requirements. The following tables summarizes our Stock Option activity under the Plan during the nine months ended June 29, 2024 (in thousands, except per share amounts):

 

 

Number of Options

 

 

Weighted Average
Exercise Price

 

Outstanding, Beginning as of October 1, 2023

 

 

3,308

 

 

$

18.10

 

Granted

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Forfeited/Expired

 

 

(1,165

)

 

 

17.76

 

Balance, Ending as of June 29, 2024

 

 

2,143

 

 

$

18.29

 

 

 

 

 

 

 

 

Vested and exercisable as of June 29, 2024

 

 

1,689

 

 

$

18.31

 

 

12


 

 

 

As of June 29, 2024

 

Aggregate intrinsic value of options outstanding

 

$

 

Unamortized value of unvested stock options

 

$

1,060

 

Weighted average years that expense is expected to be recognized

 

 

0.5

 

Weighted average remaining contractual years outstanding

 

 

6.8

 

Restricted Stock Units and Performance Units

RSUs represent grants that vest ratably upon the satisfaction of time-based requirements. PSUs represent grants potentially issuable in the future based upon the Company’s achievement of certain performance conditions. The fair value of our RSUs and PSUs are calculated based on the Company’s stock price on the date of the grant.

The following table summarizes our RSU and PSU activity under the Plan during the nine months ended June 29, 2024 (in thousands, except per share amounts):

 

 

Number of RSUs/PSUs

 

 

Weighted Average
Grant Date Fair Value

 

Outstanding, Beginning as of October 1, 2023

 

 

2,084

 

 

$

11.92

 

Granted

 

 

2,086

 

 

 

5.45

 

Vested

 

 

(727

)

 

 

9.23

 

Forfeited

 

 

(467

)

 

 

10.90

 

Balance, Ending June 29, 2024

 

 

2,976

 

 

$

8.20

 

 

During the nine months ended June 29, 2024, 0.4 million PSUs were granted subject to the Company achieving certain adjusted net income and sales performance targets on a cumulative basis during fiscal years 2024 and 2025. The criteria are based on a range of these performance targets in which participants may earn between 0% to 200% of the base number of awards granted. The weighted average grant date fair value of the PSUs was $5.43. The Company assesses the attainment of target payout rates each reporting period. Equity-based compensation expense is recognized for awards deemed probable of vesting.

 

In December 2022, the Company granted 0.3 million PSUs subject to the Company achieving certain adjusted net income and sales performance targets on a cumulative basis during each of the fiscal years 2023, 2024, and 2025. The criteria are based on a range of these performance targets in which participants may earn between 0% to 200% of the base number of awards granted. As of June 29, 2024, the performance targets had not been met for the PSUs to vest, and no PSUs had vested as of such date.

 

 

 

As of June 29, 2024

 

Unamortized value of unvested RSUs/PSUs

 

$

17,548

 

Weighted average period (years) expense is expected to be recognized

 

 

2.6

 

During the three months ended June 29, 2024 and July 1, 2023, equity-based compensation expense was $2.2 million and $2.6 million, respectively. During the nine months ended June 29, 2024 and July 1, 2023, equity-based compensation expense was $7.6 million and $9.2 million, respectively. Equity-based compensation expense is reported in selling, general, & administrative expenses (“SG&A”) in our condensed consolidated statements of operations.

13


Table of Contents

Note 14—Earnings Per Share

The following is a reconciliation of basic weighted average common shares outstanding to diluted weighted average common shares outstanding (in thousands, except per share amounts):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

June 29, 2024

 

 

July 1, 2023

 

 

June 29, 2024

 

 

July 1, 2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

60,650

 

 

$

72,547

 

 

$

(13,456

)

 

$

10,761

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic

 

 

184,834

 

 

 

183,932

 

 

 

184,614

 

 

 

183,725

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

RSUs

 

 

27

 

 

 

828

 

 

 

 

 

 

1,027

 

Weighted average shares outstanding - diluted

 

 

184,861

 

 

 

184,760

 

 

 

184,614

 

 

 

184,752

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

0.33

 

 

$

0.39

 

 

$

(0.07

)

 

$

0.06

 

Diluted earnings per share

 

$

0.33

 

 

$

0.39

 

 

$

(0.07

)

 

$

0.06

 

 

The following number of weighted-average potentially dilutive shares were excluded from the calculation of diluted earnings per share because the effect of including such shares would have been antidilutive (in thousands):

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

 

June 29, 2024

 

 

July 1, 2023

 

 

June 29, 2024

 

 

July 1, 2023

 

Stock Options

 

 

 

2,253

 

 

 

3,502

 

 

 

2,780

 

 

 

3,591

 

RSUs

 

 

 

2,351

 

 

 

1,587

 

 

 

1,459

 

 

 

778

 

Total

 

 

 

4,604

 

 

 

5,089

 

 

 

4,239

 

 

 

4,369

 

 

14


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read together with our condensed consolidated financial statements and related notes, which are included elsewhere in this Quarterly Report on Form 10-Q. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Actual results or outcomes may differ materially from those anticipated in these forward-looking statements, which are subject to risks, uncertainties, and other factors, including those described in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023 and in our other filings with the SEC.

We operate on a fiscal calendar that results in a fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to September 30th. In a 52-week fiscal year, each quarter contains 13 weeks of operations; in a 53-week fiscal year, each of the first, second and third quarters includes 13 weeks of operations and the fourth quarter includes 14 weeks of operations. References to the three months ended June 29, 2024 and July 1, 2023 refer to the 13 weeks ended June 29, 2024 and July 1, 2023, respectively. References to the nine months ended June 29, 2024 and July 1, 2023 refer to the 39 weeks ended June 29, 2024 and July 1, 2023, respectively.

Our Company

We are the largest and most trusted direct-to-consumer brand in the $15 billion United States pool and spa care industry, serving residential and professional consumers. Founded in 1963, we are the only direct-to-consumer pool and spa care brand with national scale, operating an integrated marketing and distribution ecosystem powered by a physical network of over 1,000 branded locations and a robust digital platform. We offer an extensive assortment of professional-grade products, the majority of which are exclusive to Leslie’s, as well as certified installation and repair services, all of which are essential to the ongoing maintenance of pools and spas. Our dedicated team of associates, pool and spa care experts, and experienced service technicians are passionate about empowering our consumers with the knowledge, products, and solutions necessary to confidently maintain and enjoy their pools and spas. The considerable scale of our integrated marketing and distribution ecosystem, which is powered by our direct-to-consumer network, uniquely enables us to efficiently reach and service every pool and spa in the continental United States.

We operate primarily in the pool and spa aftermarket industry, which is one of the most fundamentally attractive consumer categories given its scale, predictability, and growth outlook. More than 80% of our assortment is comprised of non-discretionary products essential to the care of residential and commercial pools and spas. Our assortment includes chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. We also offer important essential services, such as equipment installation and repair for residential consumers and professional pool operators. Consumers receive the benefit of extended vendor warranties on purchased products from our locations and on installations or repairs from our certified in-field technicians. We offer complimentary, commercial-grade in-store water testing and analysis via our proprietary AccuBlue® system, which increases consumer engagement, conversion, basket size, and loyalty, resulting in higher lifetime value. Our water treatment expertise is powered by data and intelligence accumulated from the millions of water tests we have performed over the years, positioning us as the most trusted water treatment service provider in the industry. Due to the non-discretionary nature of our products and services, our business has historically delivered strong growth and profitability in challenging market environments, including through the Great Recession and the COVID-19 pandemic.

We have a legacy of leadership and disruptive innovation. Since our founding in 1963, we have been the leading innovator in our category and have provided our consumers with the most advanced pool and spa care available. As we have scaled, we have leveraged our competitive advantages to strategically reinvest in our business and intellectual property to develop new value-added capabilities. We pioneered complimentary in-store water testing, offered complimentary in-store equipment repair services, introduced the industry’s first loyalty program, and developed an expansive platform of owned and exclusive brands. These differentiated capabilities allow us to meet the needs of any pool and spa owner, whether they care for their pool or spa themselves or rely on a professional, whenever, wherever, and however they choose to engage with us.

Key Factors and Measures We Use to Evaluate Our Business

We consider a variety of financial and operating measures in assessing the performance of our business. The key measures we use under United States generally accepted accounting principles (“GAAP”) are sales, gross profit and gross margin, selling, general and administrative expenses (“SG&A”), and operating income (loss). The key non-GAAP measures and other operating measures we use are comparable sales, comparable sales growth, Adjusted EBITDA, Adjusted net income (loss), and Adjusted diluted earnings per share.

15


Table of Contents

Sales

We offer a broad range of products that consists of regularly purchased, non-discretionary pool and spa maintenance items such as chemicals, equipment, cleaning accessories and parts, as well as installation and repair services for pool and spa equipment. Our offering of proprietary, owned, and third-party brands across diverse product categories drives sales growth by attracting new consumers and encouraging repeat visits from our existing consumers. Revenue from merchandise sales at retail locations is recognized at the point of sale, revenue from services is recognized when the services are rendered, and revenue from e-commerce merchandise sales is generally recognized upon shipment of the merchandise. Revenue is recorded net of related discounts and sales tax. Payment from retail customers is generally at the point of sale and payment terms for professional pool operator customers are based on our credit requirements and generally have terms of less than 60 days. When we receive payment from a consumer before the consumer has taken possession of the merchandise or the service has been performed, the amount received is recorded as deferred revenue or as a customer deposit until the sale or service is complete. Sales are impacted by weather, seasonality, product mix and availability, promotional and competitive activities, the spending habits of our consumers, as well as inflation and interest rates. Growth of our sales is primarily driven by comparable sales growth and expansion of our locations in existing and new markets.

Comparable Sales and Comparable Sales Growth

We measure comparable sales growth as the increase or decrease in sales recorded by the comparable base in any reporting period, compared to sales recorded by the comparable base in the prior reporting period. The comparable base includes sales through our locations and through our e-commerce websites and third-party marketplaces. Comparable sales growth is a key measure used by management and our board of directors to assess our financial performance.

We consider a new or acquired location comparable in the first full month after it has completed one year of sales. Closed locations become non-comparable during their last partial month of operation. Locations that are relocated are considered comparable at the time the relocation is complete. Comparable sales is not calculated in the same manner by all companies, and accordingly, is not necessarily comparable to similarly titled measures of other companies and may not be an appropriate measure for performance relative to other companies.

The number of new locations reflects the number of locations opened during a particular reporting period. New locations require an initial capital investment in location buildouts, fixtures, and equipment, which we amortize over time as well as cash required for inventory.

As of June 29, 2024, we operated over 1,000 locations in 39 states across the United States. We owned 27 locations and leased the remainder of our locations. Our initial lease terms are typically five years with options to renew for multiple successive five-year periods. We evaluate new opportunities in new and existing markets based on the number of pools and spas in the market, competition, our existing locations, availability and cost of real estate, and distribution and operating costs of our locations. We review the performance of our locations on a regular basis and evaluate opportunities to strategically close locations to improve our profitability. Our limited investment costs in individual locations and our ability to transfer sales to our extensive network of remaining locations and e-commerce websites allows us to improve profitability as a result of any strategic closures.

Gross Profit and Gross Margin

Gross profit is equal to our sales less our cost of merchandise and services sold. Cost of merchandise and services sold reflects the direct cost of purchased merchandise, costs to package certain chemical products, including direct materials and labor, costs to provide services, including labor and materials, as well as distribution and occupancy costs. The direct cost of purchased merchandise includes vendor rebates. We recognize vendor rebates based on historical data. Distribution costs include warehousing and transportation expenses, including costs associated with third-party fulfillment centers used to ship merchandise to our e-commerce consumers. Occupancy costs include the rent, common area maintenance, real estate taxes, and depreciation and amortization costs of all retail locations. These costs are significant and are expected to continue to increase proportionate to our growth.

Gross margin is gross profit as a percentage of our sales. Gross margin is impacted by merchandise costs, pricing and promotions, product mix and availability, inflation, and service costs, which can vary. Our proprietary brands, custom-formulated products, and vertical integration provide us with cost savings, as well as greater control over product availability and quality as compared to other companies in the industry. Gross margin is also impacted by the costs of distribution and occupancy costs, which can vary.

Our gross profit is variable in nature and generally follows changes in sales. The components of our cost of merchandise and services sold may not be comparable to the components of cost of sales or similar measures of other companies. As a result, our gross profit and gross margin may not be comparable to similar data made available by other companies.

16


Table of Contents

Selling, General and Administrative Expenses

Our SG&A includes selling and operating expenses across our retail locations and digital platform, and our corporate-level general and administrative expenses. Selling and operating expenses at retail locations include payroll, bonus and benefit costs for personnel, supplies, and credit and debit card processing costs. Corporate expenses include payroll, bonus, and benefit costs for our corporate and field support functions, equity-based compensation, marketing and advertising, insurance, utilities, occupancy costs related to our corporate office facilities, professional services, and depreciation and amortization for all assets, except those related to our retail locations and distribution operations, which are included in cost of merchandise and services sold. Selling and operating expenses generally vary proportionately with sales and the change in the number of locations. In contrast, general and administrative expenses are generally not directly proportional to sales and the change in the number of locations and may increase over time to support our growth and public company obligations. The components of our SG&A may not be comparable to the components of similar measures of other companies.

Operating Income (Loss)

Operating income (loss) is gross profit less SG&A. Operating income (loss) excludes interest expense, loss on debt extinguishment, income tax expense (benefit), and other (income) expenses, net. We use operating income (loss) as an indicator of the productivity of our business and our ability to manage expenses.

Adjusted EBITDA

Adjusted EBITDA is defined as earnings before interest (including amortization of debt issuance costs), taxes, depreciation and amortization, management fees, equity-based compensation expense, loss (gain) on debt extinguishment, loss (gain) on asset and contract dispositions, executive transition costs, severance, costs related to equity offerings, strategic project costs, merger and acquisition costs, and other non-recurring, non-cash or discrete items. Adjusted EBITDA is a key measure used by management and our board of directors to assess our financial performance. Adjusted EBITDA is also frequently used by analysts, investors, and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures. We use Adjusted EBITDA to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other companies using similar measures.

Adjusted EBITDA is not a recognized measure of financial performance under GAAP but is used by some investors to determine a company’s ability to service or incur indebtedness. Adjusted EBITDA is not calculated in the same manner by all companies, and accordingly, is not necessarily comparable to similarly titled measures of other companies and may not be an appropriate measure for performance relative to other companies. Adjusted EBITDA should not be construed as an indicator of a company’s operating performance in isolation from, or as a substitute for, net income (loss), cash flows from operations or cash flow data, all of which are prepared in accordance with GAAP. We have presented Adjusted EBITDA solely as supplemental disclosure because we believe it allows for a more complete analysis of results of operations. Adjusted EBITDA is not intended to represent, and should not be considered more meaningful than, or as an alternative to, measures of operating performance as determined in accordance with GAAP. In the future, we may incur expenses or charges such as those added back to calculate Adjusted EBITDA. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these items.

Adjusted Net Income (Loss) and Adjusted Diluted Earnings per Share

Adjusted net income (loss) and Adjusted diluted earnings per share are additional key measures used by management and our board of directors to assess our financial performance. Adjusted net income (loss) and Adjusted diluted earnings per share are also frequently used by analysts, investors, and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures.

Adjusted net income (loss) is defined as net income (loss) adjusted to exclude management fees, equity-based compensation expense, loss (gain) on debt extinguishment, loss (gain) on asset and contract dispositions, executive transition costs, severance, costs related to equity offerings, strategic project costs, merger and acquisition costs, and other non-recurring, non-cash, or discrete items. Adjusted diluted earnings per share is defined as Adjusted net income (loss) divided by the diluted weighted average number of common shares outstanding.

17


Table of Contents

Factors Affecting the Comparability of our Results of Operations

Our reported results have been affected by, among other events, the following events, which must be understood in order to assess the comparability of our period-to-period financial performance and condition.

Impact of Macroeconomic Events and Uncertainties

Our financial performance and condition may be impacted to varying extents from period to period by macroeconomic and geopolitical developments, including public health crises, escalating global conflicts, supply chain disruptions, labor market constraints, rising rates of inflation, rising interest rates, general economic slowdown, and potential failures among financial institutions. The direct and indirect impact COVID-19 has had on our financial and operating performance since 2020 has made period-to-period analysis and accurate forecasting difficult. Due to the non-discretionary nature of our products and services, our business delivered strong growth and profitability throughout the pandemic, in spite of restrictions on the operation of our locations and distribution facilities. Significant disruption to our supply chain for products we sell, as a result of COVID-19, geopolitical conflict or otherwise, can also have a material impact on our sales and earnings and cause unpredictable changes in results. In addition, we believe adverse macroeconomic trends and uncertainties including persistent inflation and high interest rates also increase consumers’ sensitivity to price and result in cost-conscious behavior inclusive of high ticket items, which can result in corresponding declines in sales and/or gross profit.

An additional uncertainty that can impact our results of operations is consumer purchasing patterns. Due to the highly unstable supply of granular chlorine compounds over the last three years, we believe some customers stockpiled chemicals, resulting in unexpected changes in demand. As a result of such behavior, our revenue may be higher than normal during the periods of stockpiling and may be lower than normal during the periods after stockpiling has occurred.

18


Table of Contents

 

Results of Operations

We derived our condensed consolidated statements of operations for the three and nine months ended June 29, 2024 and July 1, 2023 from our condensed consolidated financial statements. Our historical results are not necessarily indicative of the results that may be expected in the future. The following table summarizes key components of our results of operations for the periods indicated, both in dollars and as a percentage of our sales (in thousands, except per share amounts):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

Statements of Operations Data:

 

June 29, 2024

 

 

July 1, 2023

 

 

June 29, 2024

 

 

July 1, 2023

 

Sales

 

$

569,638

 

 

$

610,891

 

 

$

932,262

 

 

$

1,018,839

 

Cost of merchandise and services sold

 

 

340,798

 

 

 

359,295

 

 

 

598,686

 

 

 

630,777

 

Gross profit

 

 

228,840

 

 

 

251,596

 

 

 

333,576

 

 

 

388,062

 

Selling, general and administrative expenses

 

 

131,145

 

 

 

135,789

 

 

 

302,879

 

 

 

324,427

 

Operating income

 

 

97,695

 

 

 

115,807

 

 

 

30,697

 

 

 

63,635

 

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

18,156

 

 

 

17,675

 

 

 

53,380

 

 

 

48,282

 

Total other expense

 

 

18,156

 

 

 

17,675

 

 

 

53,380

 

 

 

48,282

 

Income (loss) before taxes

 

 

79,539

 

 

 

98,132

 

 

 

(22,683

)

 

 

15,353

 

Income tax expense (benefit)

 

 

18,889

 

 

 

25,585

 

 

 

(9,227

)

 

 

4,592

 

Net income (loss)

 

$

60,650

 

 

$

72,547

 

 

$

(13,456

)

 

$

10,761

 

Earnings per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.33

 

 

$

0.39

 

 

$

(0.07

)

 

$

0.06

 

Diluted

 

$

0.33

 

 

$

0.39

 

 

$

(0.07

)

 

$

0.06

 

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

184,834

 

 

 

183,932

 

 

 

184,614

 

 

 

183,725

 

Diluted

 

 

184,861

 

 

 

184,760

 

 

 

184,614

 

 

 

184,752

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage of Sales(1)

 

(%)

 

 

(%)

 

 

(%)

 

 

(%)

 

Sales

 

 

100.0

 

 

 

100.0

 

 

 

100.0

 

 

 

100.0

 

Cost of merchandise and services sold

 

 

59.8

 

 

 

58.8

 

 

 

64.2

 

 

 

61.9

 

Gross margin

 

 

40.2

 

 

 

41.2

 

 

 

35.8

 

 

 

38.1

 

Selling, general and administrative expenses

 

 

23.0

 

 

 

22.2

 

 

 

32.5

 

 

 

31.8

 

Operating income

 

 

17.2

 

 

 

19.0

 

 

 

3.3

 

 

 

6.2

 

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

3.2

 

 

 

2.9

 

 

 

5.7

 

 

 

4.7

 

Total other expense

 

 

3.2

 

 

 

2.9

 

 

 

5.7

 

 

 

4.7

 

Income (loss) before taxes

 

 

14.0

 

 

 

16.1

 

 

 

(2.4

)

 

 

1.5

 

Income tax expense (benefit)

 

 

3.3

 

 

 

4.2

 

 

 

(1.0

)

 

 

0.5

 

Net income (loss)

 

 

10.6

 

 

 

11.9

 

 

 

(1.4

)

 

 

1.1

 

Other Financial and Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

Number of new and acquired locations, net

 

 

10

 

 

 

12

 

 

 

13

 

 

 

19

 

Number of locations open at end of period

 

 

1,020

 

 

 

1,009

 

 

 

1,020

 

 

 

1,009

 

Comparable sales growth(2)

 

 

(4.0

)%

 

 

(11.8

)%

 

 

(4.1

)%

 

 

(10.9

)%

Adjusted EBITDA(3)

 

$

109,469

 

 

$

129,038

 

 

$

65,771

 

 

$

108,683

 

Adjusted EBITDA as a percentage of sales(3)

 

 

19.2

%

 

 

21.1

%

 

 

7.1

%

 

 

10.7

%

Adjusted net income (loss)(3)

 

$

63,297

 

 

$

76,362

 

 

$

(5,465

)

 

$

25,370

 

Adjusted diluted earnings per share

 

$

0.34

 

 

$

0.41

 

 

$

(0.03

)

 

$

0.14

 

 

(1)
Components may not add to totals due to rounding.
(2)
See the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Key Factors and Measures We Use to Evaluate Our Business.”
(3)
The tables below provide a reconciliation from our net income (loss) to Adjusted EBITDA and net income (loss) to Adjusted net income (loss) for the three and nine months ended June 29, 2024 and July 1, 2023 (in thousands).

 

19


Table of Contents

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

June 29, 2024

 

 

July 1, 2023

 

 

June 29, 2024

 

 

July 1, 2023

 

Net income (loss)

 

$

60,650

 

 

$

72,547

 

 

$

(13,456

)

 

$

10,761

 

Interest expense

 

 

18,156

 

 

 

17,675

 

 

 

53,380

 

 

 

48,282

 

Income tax expense (benefit)

 

 

18,889

 

 

 

25,585

 

 

 

(9,227

)

 

 

4,592

 

Depreciation and amortization expense(1)

 

 

8,246

 

 

 

8,144

 

 

 

24,419

 

 

 

25,569

 

Equity-based compensation expense(2)

 

 

2,246

 

 

 

2,754

 

 

 

7,683

 

 

 

9,460

 

Strategic project costs(3)

 

 

395

 

 

 

749

 

 

 

1,058

 

 

 

2,763

 

Executive transition costs and other(4)

 

 

887

 

 

 

1,584

 

 

 

1,914

 

 

 

7,256

 

Adjusted EBITDA

 

$

109,469

 

 

$

129,038

 

 

$

65,771

 

 

$

108,683

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

June 29, 2024

 

 

July 1, 2023

 

 

June 29, 2024

 

 

July 1, 2023

 

Net income (loss)

 

$

60,650

 

 

$

72,547

 

 

$

(13,456

)

 

$

10,761

 

Equity-based compensation expense(2)

 

 

2,246

 

 

 

2,754

 

 

 

7,683

 

 

 

9,460

 

Strategic project costs(3)

 

 

395

 

 

 

749

 

 

 

1,058

 

 

 

2,763

 

Executive transition costs and other(4)

 

 

887

 

 

 

1,584

 

 

 

1,914

 

 

 

7,256

 

Tax effects of these adjustments(5)

 

 

(881

)

 

 

(1,272

)

 

 

(2,664

)

 

 

(4,870

)

Adjusted net income (loss)

 

$

63,297

 

 

$

76,362

 

 

$

(5,465

)

 

$

25,370

 

 

(1)
Includes depreciation related to our distribution centers and store locations, which is reported in cost of merchandise and services sold and selling, general and administrative in our condensed consolidated statements of operations.
(2)
Represents charges related to equity-based compensation and our related payroll tax expense, which are reported in SG&A in our condensed consolidated statements of operations.
(3)
Represents non-recurring costs, such as third-party consulting costs related to first-generation technology initiatives, replacements of systems that have been no longer supported by our vendors, investment in and development of new products outside of the course of continuing operations, or other discrete strategic projects that are infrequent or unusual in nature and potentially distortive to continuing operations. These items are reported in SG&A in our condensed consolidated statements of operations.
(4)
Includes certain senior executive transition costs and severance associated with completed corporate restructuring activities across the organization, losses (gains) on asset dispositions, merger and acquisition costs, and other non-recurring, non-cash, or discrete items as determined by management. Amounts are reported in SG&A in our condensed consolidated statements of operations.
(5)
Represents the tax effect of the total adjustments based on our combined U.S. federal and state statutory tax rates. Amounts are reported in income tax expense (benefit) in our condensed consolidated statements of operations.

Selected Financial Information

Sales

Sales decreased to $569.6 million for the three months ended June 29, 2024, from $610.9 million in the prior year period, a decrease of $41.3 million, or 6.8%. The decrease was primarily driven by a reduction in average order value of approximately 5.0% due to chemical pricing actions and a decrease in transaction volume of 1.7%. Comparable sales decreased $21.6 million relative to the prior year period. Non-comparable sales, including acquisitions and new stores, contributed $2.6 million in the period.

During the three months ended June 29, 2024, our sales were adversely impacted by cold and wet weather in April and May which reduced the number of pool days in non-seasonal markets and delayed the start of pool season in seasonal markets. Sales improved in June with warm and dry weather, but it was not enough to offset the lost pool days in April and May. Additionally, sales were negatively impacted by weakness in large ticket categories due the cumulative effect of high inflation and interest rates, which contributed to the reduction in average order value. In addition, this year we experienced a calendar shift in which we lost two high volume selling days during the core pool season, and gained two lower volume selling days at the end of March and early April.

Sales decreased to $932.3 million for the nine months ended June 29, 2024, from $1,018.8 million in the prior year period, a decrease of $86.6 million, or 9.3%. The decrease was primarily driven by a reduction in average order value of approximately 5.7% due to chemical pricing actions and a decrease in transaction volume of 2.7%. Comparable sales decreased $36.5 million relative to the prior year period. Non-comparable sales, including acquisitions and new stores, contributed $6.4 million in the period.

 

Gross Profit and Gross Margin

20


Table of Contents

Gross profit decreased to $228.8 for the three months ended June 29, 2024 from $251.6 million in the prior year period, a decrease of $22.8 million, or 9.9%. Gross margin decreased to 40.2% compared to 41.2% in the prior year period, which represents a decrease of 100 basis points. The decrease in gross margin was primarily driven by negative impacts of 112 basis points from the June 2023 chemical pricing actions, 85 basis points from the expensing of previously capitalized distribution center costs due to significant reductions in inventory during the period and 46 basis points from deleverage on occupancy costs. These impacts were partially offset by a 90 basis point reduction in inventory adjustments and distribution costs. Gross profit decreased to $333.6 million for the nine months ended June 29, 2024 from $388.1 million in the prior year period, a decrease of $54.5 million, or 16.3%. Gross margin decreased to 35.8% compared to 38.1% in the prior year period, which represents a decrease of approximately 230 basis points. The decrease in gross margin was primarily driven by negative impacts of 121 basis points from the June 2023 chemical pricing actions, 102 basis points from deleverage on occupancy costs, and 83 basis points from the expensing of previously capitalized distribution center costs due to significant reductions in inventory during the period. These impacts were partially offset by an 82 basis point reduction in inventory adjustments and distribution costs.

Selling, General and Administrative Expenses

SG&A decreased to $131.1 million during the three months ended June 29, 2024 from $135.8 million in the prior year period, a decrease of $4.6 million, or 3.5%. The decrease in SG&A was primarily related to a decrease in merchant fees of $2.4 million associated with lower sales, and lower payroll costs of $2.3 million as we continue to make solid progress on our cost management initiatives.

SG&A decreased to $302.9 million during the nine months ended June 29, 2024 from $324.4 million in the prior year period, a decrease of $21.5 million, or 6.6%. The decrease in SG&A was primarily related to lower payroll costs of $6.5 million, a decrease in merchant fees of $4.7 million associated with lower sales, lower executive transition costs of $2.2 million and a decrease in equity compensation expense of $1.8 million.

Interest Expense

Interest expense increased to $18.2 million for the three months ended June 29, 2024 from $17.7 million in the prior year period, an increase of $0.5 million. Interest expense increased to $54.4 million for the nine months ended June 29, 2024 from $48.3 million in the prior year period, an increase of $6.1 million.

These increase for the three and nine months ended was due to higher interest rates on our Term Loan.

Income Taxes

Income tax expense decreased to $18.9 million for the three months ended June 29, 2024 compared to $25.6 million in the prior year period, a decrease of $6.7 million. Income tax benefit was $9.2 million for the nine months ended June 29, 2024 compared to $4.6 million of income tax expense in the prior year period, a change of $13.8 million. These changes in both the three and nine months ended June 29, 2024 compared to the prior year period were primarily attributable to a pretax loss for the nine months ended June 29, 2024, compared to pretax income in the prior year period.

The effective income tax rate was 23.8% and a benefit of 40.7% for the three and nine months ended June 29, 2024, respectively. The effective income tax rate was 26.1% and 29.9% for the three and nine months ended July 1, 2023, respectively. The differences in effective tax rates during the periods are primarily attributable to the pretax income or loss during those periods.

Net Income (Loss) and Diluted Earnings per Share

Net income decreased to $60.7 million for the three months ended June 29, 2024 compared to $72.5 million in the prior year period, an decrease of $11.9 million. Net loss was $13.5 million for the nine months ended June 29, 2024 compared to net income of $10.8 million in the prior year period, a change of $24.3 million. These changes in net income (loss) were primarily due to decreases in gross profit, partially offset by a reduction in selling, general and administrative expense. Diluted earnings per share was $0.33 for the three months ended June 29, 2024 compared to $0.39 in the prior year period. Diluted earnings per share was $(0.07) for the nine months ended June 29, 2024 compared to diluted earnings per share of $0.06 in the prior year period.

Adjusted net income decreased to $63.3 million for the three months ended June 29, 2024 compared to $76.4 million in the prior year period, a decrease of $13.1 million. Adjusted net loss was $5.5 million for the nine months ended June 29, 2024 compared to adjusted net income of $25.4 million in the prior year period, a change of $30.9 million. Adjusted diluted earnings per share was $0.34 for the three months ended June 29, 2024 compared to $0.41 in the prior year period. Adjusted diluted earnings per share was $(0.03) for the nine months ended June 29, 2024 compared to adjusted diluted earnings per share of $0.14 in the prior year period.

21


Table of Contents

Adjusted EBITDA

Adjusted EBITDA decreased to $109.5 million for the three months ended June 29, 2024 compared to $129.0 million in the prior year period, a decrease of $19.5 million. Adjusted EBITDA decreased to $65.8 million for the nine months ended June 29, 2024 compared to $108.7 million in the prior year period, a decrease of $42.9 million. These decreases were primarily due to decreases in gross profit.

Seasonality and Quarterly Fluctuations

Our business is highly seasonal. Sales and earnings are highest during the third and fourth fiscal quarters, which include April through September, and represent the peak months of swimming pool use. Sales are substantially lower during our first and second fiscal quarters. We have a long track record of investing in our business throughout the year, including in operating expenses, working capital, and capital expenditures related to new locations and other growth initiatives. While these investments drive performance during the primary selling season in our third and fourth fiscal quarters, they have a negative impact on our earnings and cash flow during our first and second fiscal quarters.

We typically experience a build-up of inventory and accounts payable during the first and second fiscal quarters in anticipation of the peak swimming pool supply selling season. We negotiate extended payment terms with certain of our primary suppliers as we receive merchandise in December through March, and we pay for merchandise in April through July.

The principal external factor affecting our business is weather. Hot weather can increase purchases of chemicals and other non-discretionary products as well as purchases of discretionary products and can drive increased purchases of installation and repair services. Unseasonably cool weather or significant amounts of rainfall during the peak pool sales season can reduce chemical consumption in pools and spas and decrease consumer purchases of our products and services. In addition, unseasonably early or late warming trends can increase or decrease the length of the pool season and impact time around pool openings and closings, and therefore, our total sales and timing of our sales.

We generally open new locations before our peak selling season begins and we generally close locations after our peak selling season ends. We expect that our quarterly results of operations will fluctuate depending on the timing and amount of sales contributed by new locations.

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are net cash provided by operating activities and borrowing availability under our Revolving Credit Facility. Historically, we have funded working capital requirements, capital expenditures, payments related to acquisitions, debt service requirements and repurchases of shares of our common stock with internally generated cash on hand and through our Revolving Credit Facility.

Cash and cash equivalents consist primarily of cash on deposit with banks. Cash and cash equivalents totaled $74.4 million and $55.4 million as of June 29, 2024 and September 30, 2023, respectively. We had no amounts outstanding on our Revolving Credit Facility as of June 29, 2024 and September 30, 2023.

Our primary working capital requirements are for the purchase of inventory, payroll, rent, other facility costs, distribution costs, and general and administrative costs. Our working capital requirements fluctuate during the year, driven primarily by seasonality and the timing of inventory purchases.

Our capital expenditures are primarily related to infrastructure-related investments, including investments related to upgrading and maintaining our information technology systems, ongoing location improvements, expenditures related to our distribution centers, and new location openings. We expect to fund capital expenditures from net cash provided by operating activities.

Based on our growth plans, we believe our cash and cash equivalents position, net cash provided by operating activities and borrowing availability under our Revolving Credit Facility will be adequate to finance our working capital requirements, planned capital expenditures, strategic acquisitions, share repurchases, and debt service over the next 12 months and thereafter. If cash provided by operating activities and borrowings under our Revolving Credit Facility are not sufficient or available to meet our capital requirements, then we may need to obtain additional equity or debt financing. There can be no assurance that equity or debt financing will be available to us if we need it or, if available, whether the terms will be satisfactory to us.

As of June 29, 2024, outstanding standby letters of credit totaled $10.9 million and, after considering borrowing base restrictions, we had $239.1 million of available borrowing capacity under the terms of the Revolving Credit Facility. As of June 29, 2024, we were in compliance with the covenants under the Revolving Credit Facility and our Term Loan agreements.

22


Table of Contents

Summary of Cash Flows

A summary of our cash flows from operating, investing, and financing activities is presented in the following table (in thousands):

 

 

 

Nine Months Ended

 

 

 

June 29, 2024

 

 

July 1, 2023

 

Net cash provided by (used in) operating activities

 

$

60,410

 

 

$

(74,813

)

Net cash used in investing activities

 

 

(34,247

)

 

 

(40,898

)

Net cash (used in) provided by financing activities

 

 

(7,145

)

 

 

22,848

 

Net increase (decrease) in cash and cash equivalents

 

$

19,018

 

 

$

(92,863

)

 

Cash Provided by (Used in) Operating Activities

Net cash provided by operating activities was $60.4 million for the nine months ended June 29, 2024 compared to net cash used in operating activities of $74.8 million in the prior year period, an increase of $135.2 million. The increase was primarily driven by changes in working capital related to reductions in accounts payable of $50.4 million and product inventories of $9.6 million.

Cash Used in Investing Activities

Net cash used in investing activities was $34.2 million for the nine months ended June 29, 2024 compared to $40.9 million in the prior year period, a decrease of $6.7 million. This decrease was primarily driven by a decrease in investments for business acquisitions of $15.5 million, partially offset by an increase in purchases of property and equipment of $7.6 million.

Cash (Used in) Provided by Financing Activities

Net cash used in financing activities for the nine months ended June 29, 2024 was $7.1 million compared to net cash provided by financing activities of $22.8 million in the prior year period, a decrease of $29.9 million. This decrease was primarily driven by lower borrowings on our Revolving Credit Facility during the period.

Share Repurchase Program

On December 3, 2021, the board of directors authorized a share repurchase program for up to an aggregate of $300 million of the Company’s outstanding shares of common stock over a period of three years, expiring December 31, 2024. As of June 29, 2024, approximately $147.7 million remained available for future purchases under our share repurchase program (see Note 12—Share Repurchase Program to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q).

23


Table of Contents

Contractual Obligations and Other Commitments

There have been no material changes to our contractual obligations and other commitments during the three months and nine ended June 29, 2024 from those disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

Critical Accounting Estimates

The preparation of our condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of sales and expenses during the reported periods. The SEC has defined a company’s critical accounting policies as the ones that are most important to the portrayal of a company’s financial condition and results of operations, and which require a company to make its most difficult and subjective judgments. Based on this definition, we have identified the critical accounting policies and judgments, which are disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023. We base these estimates on historical results and various other assumptions we believe to be reasonable, all of which form the basis for making estimates concerning the carrying values of assets and liabilities that are not readily available from other sources. Actual results may differ from these estimates.

There have been no material changes to our critical accounting estimates during the three and nine months ended June 29, 2024 from those disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, see Note 2—Summary of Significant Accounting Policies to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Interest Rate Risk

There have been no material changes in our primary risk exposures or management of market risks from those disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

Impact of Inflation and Deflation

There have been no material changes in our exposure to inflation or deflation from those disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

Item 4. Controls and Procedures.

Management’s Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) are designed to ensure that information required to be disclosed by us in reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the appropriate time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure. We, under the supervision of and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures as of June 29, 2024. Based on that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) have concluded that the design and operation of our disclosure controls and procedures were ineffective as the material weaknesses in internal control over financial reporting disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023 were not yet remediated as of June 29, 2024.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended June 29, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, except as described below.

24


Table of Contents

Ongoing Remediation Efforts

As previously disclosed in Part II, Item 9A, “Controls and Procedures” of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023, we are in the process of implementing a plan to address the material weaknesses in internal control over financial reporting that were disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023. We are enhancing the design and implementation of existing controls and creating new controls as needed with respect to inventory control as follows:

examination of our current controls and identification of the root cause(s) for the deficiencies;
examination and enhancement of the procedures regarding certain of our annual physical inventory counts, including the augmentation of employee training and validation of system generated reports utilized in performing certain annual physical counts and clarification of instructions as to the process for recording adjustments to inventory as a result of physical counts and validation of data used in inventory costing;
enhanced supervision of personnel during and subsequent to physical inventory counts to confirm compliance with our established policies; and
examination and enhancement of the procedures regarding the completeness and accuracy of data utilized in computing inventory reserves.

We are enhancing the design and implementation of existing controls and creating new controls as needed with respect to vendor rebates as follows:

implementation and execution of enhanced controls to detect potential material misstatements in the data utilized to calculate vendor rebates earned and timing of vendor rebate income recognition, to aid in the detection of potential deviations that may be relied upon in our financial reporting processes.

The actions we are taking are subject to continued senior management review as well as Audit Committee oversight. The material weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We are committed to continuing to improve our internal control processes, and, as we continue to evaluate and work to improve our internal control over financial reporting, we may take additional measures to address control deficiencies, or we may modify certain of our remediation measures as described above or as described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

25


Table of Contents

PART II - OTHER INFORMATION

 

We are subject to other litigation, claims, and other proceedings that arise from time-to-time in the ordinary course of business. We believe these actions are routine and incidental to the business. As of June 29, 2024, we had established reserves for claims that are probable and estimable and such reserves were not significant. While we cannot feasibly predict the outcome of these matters with certainty, we believe, based on examination of these matters, experience to date and discussions with counsel, that the ultimate liability, individually or in the aggregate, will not have a material adverse effect on our business, financial position, results of operations, or cash flows.

 

Except as set forth in Note 10 - Commitments & Contingencies to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, there have been no material changes to the legal proceedings described in Part I Item 3 “Legal Proceedings” of our Annual Report on Form 10-K for the fiscal year ended September 30, 2023.

Item 1A. Risk Factors.

There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended September 30, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities

None.

Sales of Unregistered Securities

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

(a) Information Required to be Disclosed on Form 8-K

None.

(b) Changes to Procedures for Recommending Director Nominees

Not applicable.

(c) Trading Plans

During the quarter ended June 29, 2024, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).

26


Table of Contents

Item 6. Exhibits.

Incorporated by Reference

Exhibit

Number

Exhibit Description

Form

Exhibit

Filing Date/

Period End Date

10.1

 

Executive Severance Pay Plan, dated April 23, 2024, by and between Leslie’s Poolmart, Inc and Benjamin Lindquist

 

10-Q

 

10.2

 

03/30/2024

10.2

 

Amendment No. 7, dated as of April 3, 2024, to the Credit Agreement among Leslie’s Poolmart, Inc., and the subsidiary borrowers named therein, Bank of America, N.A., as Administrative Agent, and U.S. Bank National Association, Co-Collateral Agent

 

8-K

 

10.1

 

04/09/2024

31.1*

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934

31.2*

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934

32.1+

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350

32.2+

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350

101.INS*

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

 

 

 

 

 

101.SCH*

 

Inline XBRL Taxonomy Schema Document With Embedded Linkbase Documents

 

 

 

 

 

 

104*

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

 

 

 

* Filed herewith.

+ Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

27


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

LESLIE’S, INC.

Date: August 7, 2024

By:

/s/ Scott Bowman

Scott Bowman

Chief Financial Officer

 

 

 

(Principal Financial Officer and Principal Accounting Officer)

 

28